{"id":"https://openalex.org/W63578112","doi":null,"title":"\u0410\u043d\u0442\u0438\u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0432\u043d\u044b\u0435 \u0441\u0432\u043e\u0439\u0441\u0442\u0432\u0430 \u0438 \u043d\u0435\u0439\u0440\u043e-\u0444\u0430\u0440\u043c\u0430\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043f\u0440\u043e\u0444\u0438\u043b\u044c 3-\u0444\u0435\u043d\u0438\u043b\u0441\u0443\u043b\u044c\u0444\u043e\u043d\u0438\u043b\u0442\u0438\u0435\u0442\u0430\u043d-1,1-\u0434\u0438\u043e\u043a\u0441\u0438\u0434\u0430 (\u043d69)","display_name":"\u0410\u043d\u0442\u0438\u0434\u0435\u043f\u0440\u0435\u0441\u0441\u0438\u0432\u043d\u044b\u0435 \u0441\u0432\u043e\u0439\u0441\u0442\u0432\u0430 \u0438 \u043d\u0435\u0439\u0440\u043e-\u0444\u0430\u0440\u043c\u0430\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043f\u0440\u043e\u0444\u0438\u043b\u044c 3-\u0444\u0435\u043d\u0438\u043b\u0441\u0443\u043b\u044c\u0444\u043e\u043d\u0438\u043b\u0442\u0438\u0435\u0442\u0430\u043d-1,1-\u0434\u0438\u043e\u043a\u0441\u0438\u0434\u0430 (\u043d69)","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W63578112","mag":"63578112"},"language":"ru","primary_location":{"id":"mag:63578112","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/antidepressivnye-svoystva-i-neyro-farmakologicheskiy-profil-3-fenilsulfoniltietan-1-1-dioksida-n69","pdf_url":null,"source":{"id":"https://openalex.org/S4306539551","display_name":"\u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0432\u0435\u0441\u0442\u043d\u0438\u043a \u0411\u0430\u0448\u043a\u043e\u0440\u0442\u043e\u0441\u0442\u0430\u043d\u0430","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0432\u0435\u0441\u0442\u043d\u0438\u043a \u0411\u0430\u0448\u043a\u043e\u0440\u0442\u043e\u0441\u0442\u0430\u043d\u0430","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103169614","display_name":"\u041e. \u0410. \u0418\u0432\u0430\u043d\u043e\u0432\u0430","orcid":"https://orcid.org/0000-0001-9452-5753","observed_orcids":["https://orcid.org/0000-0001-9452-5753"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u041e. \u0410. \u0418\u0432\u0430\u043d\u043e\u0432\u0430","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9452-5753","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032428809","display_name":"\u0418\u0440\u0438\u043d\u0430 \u041b\u0435\u043e\u043d\u0438\u0434\u043e\u0432\u043d\u0430 \u041d\u0438\u043a\u0438\u0442\u0438\u043d\u0430","orcid":"https://orcid.org/0000-0002-6283-5762","observed_orcids":["https://orcid.org/0000-0002-6283-5762"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0418. \u041b. \u041d\u0438\u043a\u0438\u0442\u0438\u043d\u0430","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6283-5762","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031385019","display_name":"\u0420. \u0410. \u0413\u0430\u0431\u0438\u0434\u0443\u043b\u043b\u0438\u043d","orcid":"https://orcid.org/0009-0000-8542-9997","observed_orcids":["https://orcid.org/0009-0000-8542-9997"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0420. \u0410. \u0413\u0430\u0431\u0438\u0434\u0443\u043b\u043b\u0438\u043d","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037099154","display_name":"\u0415. \u041a. \u0410\u043b\u0435\u0445\u0438\u043d","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0415. \u041a. \u0410\u043b\u0435\u0445\u0438\u043d","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037607106","display_name":"\u0415\u043b\u0435\u043d\u0430 \u042d\u0434\u043c\u0443\u043d\u0434\u043e\u0432\u043d\u0430 \u041a\u043b\u0435\u043d","orcid":"https://orcid.org/0000-0001-7538-6030","observed_orcids":["https://orcid.org/0000-0001-7538-6030"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0415. \u042d. \u041a\u043b\u0435\u043d","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7538-6030","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018132069","display_name":"\u041d. \u041d. \u041c\u0430\u043a\u0430\u0440\u043e\u0432\u0430","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u041d. \u041d. \u041c\u0430\u043a\u0430\u0440\u043e\u0432\u0430","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5046152561","display_name":"\u0424\u0435\u0440\u043a\u0430\u0442 \u0410\u0434\u0435\u043b\u044c\u0437\u044f\u043d\u043e\u0432\u0438\u0447 \u0425\u0430\u043b\u0438\u0443\u043b\u043b\u0438\u043d","orcid":"https://orcid.org/0000-0003-0564-4246","observed_orcids":["https://orcid.org/0000-0003-0564-4246"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0424. \u0410. \u0425\u0430\u043b\u0438\u0443\u043b\u043b\u0438\u043d","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0564-4246","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00884031,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"4","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.7760000228881836},{"id":"https://openalex.org/keywords/forced-swim-test","display_name":"forced swim test","score":0.9480000138282776},{"id":"https://openalex.org/keywords/immobility-time","display_name":"immobility time","score":0.9660000205039978},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.5619999766349792},{"id":"https://openalex.org/keywords/apomorphine","display_name":"apomorphine","score":0.8619999885559082},{"id":"https://openalex.org/keywords/5-hydroxytryptophan","display_name":"5-hydroxytryptophan","score":0.9819999933242798},{"id":"https://openalex.org/keywords/lethal-dose","display_name":"lethal dose","score":0.5479999780654907},{"id":"https://openalex.org/keywords/effective-dose","display_name":"effective dose","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C2777525119","wikidata":"https://www.wikidata.org/wiki/Q269111","display_name":"Apomorphine","level":4,"score":0.7994817495346069},{"id":"https://openalex.org/C2777842393","wikidata":"https://www.wikidata.org/wiki/Q407841","display_name":"Reserpine","level":2,"score":0.7875906229019165},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.5778615474700928},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45898139476776123},{"id":"https://openalex.org/C2777383412","wikidata":"https://www.wikidata.org/wiki/Q4770891","display_name":"Antagonism","level":3,"score":0.45433834195137024},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4374648630619049},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41716712713241577},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3707256317138672},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.36933284997940063},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.09883356094360352},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.06390154361724854},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:63578112","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/antidepressivnye-svoystva-i-neyro-farmakologicheskiy-profil-3-fenilsulfoniltietan-1-1-dioksida-n69","pdf_url":null,"source":{"id":"https://openalex.org/S4306539551","display_name":"\u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0432\u0435\u0441\u0442\u043d\u0438\u043a \u0411\u0430\u0448\u043a\u043e\u0440\u0442\u043e\u0441\u0442\u0430\u043d\u0430","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0432\u0435\u0441\u0442\u043d\u0438\u043a \u0411\u0430\u0448\u043a\u043e\u0440\u0442\u043e\u0441\u0442\u0430\u043d\u0430","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W81848938","https://openalex.org/W2091945221","https://openalex.org/W2407457728","https://openalex.org/W3199768894","https://openalex.org/W2187370267","https://openalex.org/W2412865688","https://openalex.org/W2495519575","https://openalex.org/W2041930616","https://openalex.org/W7100361663","https://openalex.org/W2335764779"],"abstract_inverted_index":{"Antidepressive":[0],"effects":[1],"of":[2,46,81],"3-phenylsulphothietan-1,1-dioxyde":[3],"(N69)":[4],"have":[5],"been":[6,39],"studied":[7],"in":[8,24,62],"male":[9],"mice.":[10],"N69":[11,51,83],"(2":[12],"mg/kg":[13,16,49],"and":[14,21,31,58,67,73,90],"20":[15],"i.p.)":[17],"reduces":[18],"immobility":[19],"time":[20],"depression":[22],"index":[23],"the":[25,82],"forced":[26],"swimming":[27],"test":[28],"after":[29],"acute":[30],"chronic":[32],"(14":[33],"days)":[34],"administration.":[35],"Its":[36],"effect":[37],"has":[38],"shown":[40],"to":[41,44,85],"be":[42,86],"similar":[43],"that":[45],"fluoxetine":[47],"(10":[48],"i.p.).":[50],"exhibits":[52],"antagonism":[53],"with":[54,64],"haloperidol,":[55],"apomorphine,":[56],"5-hydroxytryptophan":[57],"it":[59],"is":[60],"ineffective":[61],"tests":[63],"reserpine,":[65],"clonidine":[66],"arecoline.":[68],"The":[69],"lethal":[70],"dose":[71,75],"(50)":[72,76],"effective":[74],"values":[77],"for":[78],"intraperitoneal":[79],"administration":[80],"appear":[84],"148mg":[87],"":[88],"kg":[89],"10":[91],"mg/kg,":[92],"respectively.":[93]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}